Type
. MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nature medicine. 2012;18(2):267-73.
Type
. Absence of nucleotide-binding oligomerization domain-containing protein 2 variants in patients with leprosy and tuberculosis. International journal of immunogenetics. 2012;39(4):353-6.
Type
. [Annular skin lesions in a patient with neurological symptoms as the clue to the diagnosis of Hansen's disease]. Medicina clinica. 2012;139(14):652.
Type
. Coping with the stigma of leprosy in Northern India. Department of Anthropology. [Atlanta]: Emory University; 1999. p. 13 p.
Type
. [Reliability and agreement of two smear reading scales for classification and monitoring of multidrug therapy in leprosy patients]. Biomedica : revista del Instituto Nacional de Salud [Internet]. 2011;31(3):403-9. Available from: http://www.scielo.org.co/pdf/bio/v31n3/v31n3a12.pdf
Type
. Investigation of neuropathic pain in treated leprosy patients in Ethiopia: a cross-sectional study. Pain. 2012;153(8):1620-4.
Type
. Nail Involvement in Leprosy. Actas dermo-sifiliográficas. 2012;.
Type
. Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods. Journal of dermatological science. 2012;67(3):192-4.
Type
. Evaluation of renal profile in patients of leprosy. Journal, Indian Academy of Clinical Medicine. 2004;5(4):316-21.
Type
. Improving the quality of health care for chronic conditions. Quality and Safety in Helath Care. 2004;13(4):299–305.
Pagination
- Previous page
- Page 350
- Next page